FI47885B - - Google Patents

Info

Publication number
FI47885B
FI47885B FI02993/72A FI299372A FI47885B FI 47885 B FI47885 B FI 47885B FI 02993/72 A FI02993/72 A FI 02993/72A FI 299372 A FI299372 A FI 299372A FI 47885 B FI47885 B FI 47885B
Authority
FI
Finland
Application number
FI02993/72A
Other languages
Finnish (fi)
Other versions
FI47885C (fi
Inventor
G Arth
G Rasmussen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI47885B publication Critical patent/FI47885B/fi
Application granted granted Critical
Publication of FI47885C publication Critical patent/FI47885C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI722993A 1969-05-14 1972-10-27 Menetelmä 1,2 alfa-metyleeni-6,7 alfa-difluorimetyleeni-20-spiroks-4-e eni-3-onin valmistamiseksi FI47885C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82467269A 1969-05-14 1969-05-14
US2118370A 1970-03-19 1970-03-19

Publications (2)

Publication Number Publication Date
FI47885B true FI47885B (en:Method) 1974-01-02
FI47885C FI47885C (fi) 1974-04-10

Family

ID=26694377

Family Applications (2)

Application Number Title Priority Date Filing Date
FI701339A FI47355C (fi) 1969-05-14 1970-05-13 Menetelmä 1,2alfa-metyleeni-6,7alfa-difluorimetyleeni-20-spiroks-4-een i-3-oni-johdannaisten valmistamiseksi.
FI722993A FI47885C (fi) 1969-05-14 1972-10-27 Menetelmä 1,2 alfa-metyleeni-6,7 alfa-difluorimetyleeni-20-spiroks-4-e eni-3-onin valmistamiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI701339A FI47355C (fi) 1969-05-14 1970-05-13 Menetelmä 1,2alfa-metyleeni-6,7alfa-difluorimetyleeni-20-spiroks-4-een i-3-oni-johdannaisten valmistamiseksi.

Country Status (17)

Country Link
JP (1) JPS532865B1 (en:Method)
AR (1) AR192305A1 (en:Method)
BE (1) BE750330A (en:Method)
CA (1) CA926385A (en:Method)
CH (2) CH547785A (en:Method)
CS (2) CS151551B2 (en:Method)
DE (1) DE2023450C3 (en:Method)
DK (3) DK126992B (en:Method)
FI (2) FI47355C (en:Method)
FR (1) FR2051526B1 (en:Method)
GB (1) GB1265444A (en:Method)
IE (1) IE34194B1 (en:Method)
IL (1) IL34431A (en:Method)
NL (1) NL168844C (en:Method)
NO (1) NO131131C (en:Method)
SE (2) SE366305B (en:Method)
YU (1) YU34052B (en:Method)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3356677A (en) * 1966-04-05 1967-12-05 Syntex Corp 1alpha, 2alpha-and 6alpha, 7alpha-dihalomethylene androstenes

Also Published As

Publication number Publication date
DK127880B (en:Method) 1974-01-28
AR192305A1 (es) 1973-02-14
DK127880C (da) 1974-06-10
GB1265444A (en:Method) 1972-03-01
FI47885C (fi) 1974-04-10
CH547792A (de) 1974-04-11
SE386904B (sv) 1976-08-23
CS151552B2 (en:Method) 1973-10-19
YU117670A (en) 1978-05-15
IE34194B1 (en) 1975-03-05
CS151551B2 (en:Method) 1973-10-19
DK127505B (da) 1973-11-19
NL7006474A (en:Method) 1970-11-17
BE750330A (fr) 1970-11-13
CH547785A (de) 1974-04-11
FR2051526B1 (en:Method) 1974-04-12
DE2023450C3 (de) 1979-05-31
DE2023450B2 (de) 1978-10-05
IL34431A0 (en) 1970-07-19
NO131131C (en:Method) 1975-04-09
CA926385A (en) 1973-05-15
IE34194L (en) 1970-11-14
FI47355C (fi) 1973-11-12
IL34431A (en) 1974-03-14
NL168844C (nl) 1982-05-17
NO131131B (en:Method) 1974-12-30
FR2051526A1 (en:Method) 1971-04-09
DE2023450A1 (de) 1971-01-14
NL168844B (nl) 1981-12-16
YU34052B (en) 1978-10-31
JPS532865B1 (en:Method) 1978-02-01
SE366305B (en:Method) 1974-04-22
DK126992B (da) 1973-09-10
FI47355B (en:Method) 1973-07-31

Similar Documents

Publication Publication Date Title
AU5461069A (en:Method)
AU5712069A (en:Method)
CS148407B1 (en:Method)
CS150623B2 (en:Method)
AU427401B2 (en:Method)
CS149916B2 (en:Method)
CS152481B2 (en:Method)
AU428074B2 (en:Method)
FR2051526B1 (en:Method)
AU428129B2 (en:Method)
AU5988769A (en:Method)
AU4923469A (en:Method)
AU4949169A (en:Method)
CS149307B1 (en:Method)
CS149994B1 (en:Method)
AU5079269A (en:Method)
AU5228269A (en:Method)
CS153783B1 (en:Method)
AU5979569A (en:Method)
CS150633B2 (en:Method)
AU6077869A (en:Method)
CH1821569A4 (en:Method)
BE742130A (en:Method)
BE739876A (en:Method)
BE739779A (en:Method)